A new antiviral drug heading into clinical trials offers hope for COVID-19 treatment — in part because it can be taken as a pill
April 6, 2020 Scientists are hopeful that a new drug — called EIDD-2801 — could change the way doctors treat COVID-19. The antiviral shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.